A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R

Article ID	Journal	Published Year	Pages	File Type
5701457	Journal of Thoracic Oncology	2017	18 Pages	PDF

Abstract

Significant OS benefit was observed in patients with T790M mutation, suggesting that a larger proportion of T790M mutation might contribute to the better survival of patients with Del19.

Keywords

T790M mutation Resistance mechanisms

Related Topics

Health Sciences Medicine and Dentistry Oncology

Preview

A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R

Authors

E-E PhD, Qing PhD, Qiu-Yi MD, Jian MMed, Zhi-Hong MMed, Xu-Chao PhD, Chong-Rui PhD, Jin-Ji PhD, Hai-Yan MD, Hong-Hong MMed, Yi-Chen MD, Fei-Yu PhD, Yi-Long MD,